“The increase in leverage comes from loss of EBITDA associated with the operations that will be spun-off and the estimated debt repayment that Community could make with dividend proceeds received in the transaction,” said Moody’s.
The transaction will not have an immediate impact on CHS’ credit ratings, and its negative rating outlook remains unchanged, according to Moody’s.
CHS plans to combine 38 hospitals and its hospital management and consulting business into Quorum Health Corp. The transaction is expected to close in the second quarter of 2016.
More articles on healthcare finance:
Physicians who receive lots of pharma cash prescribe more brand-name drugs, study finds
Presence CEO says poor collections to blame for $186M operating loss
House Republicans unveil 2017 budget: 7 things for healthcare leaders to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
